BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 29355640)

  • 1. Cannabinoids induce apathetic and impulsive patterns of choice through CB1 receptors and TRPV1 channels.
    Fatahi Z; Reisi Z; Rainer G; Haghparast A; Khani A
    Neuropharmacology; 2018 May; 133():75-84. PubMed ID: 29355640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opposing roles for cannabinoid receptor type-1 (CB₁) and transient receptor potential vanilloid type-1 channel (TRPV1) on the modulation of panic-like responses in rats.
    Casarotto PC; Terzian AL; Aguiar DC; Zangrossi H; Guimarães FS; Wotjak CT; Moreira FA
    Neuropsychopharmacology; 2012 Jan; 37(2):478-86. PubMed ID: 21937980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory CB1 and activating/desensitizing TRPV1-mediated cannabinoid actions on CGRP release in rodent skin.
    Engel MA; Izydorczyk I; Mueller-Tribbensee SM; Becker C; Neurath MF; Reeh PW
    Neuropeptides; 2011 Jun; 45(3):229-37. PubMed ID: 21514666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anxiolytic effects in mice of a dual blocker of fatty acid amide hydrolase and transient receptor potential vanilloid type-1 channels.
    Micale V; Cristino L; Tamburella A; Petrosino S; Leggio GM; Drago F; Di Marzo V
    Neuropsychopharmacology; 2009 Feb; 34(3):593-606. PubMed ID: 18580871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of cannabinoid system in anterior cingulate cortex and orbitofrontal cortex modulates cost-benefit decision making.
    Khani A; Kermani M; Hesam S; Haghparast A; Argandoña EG; Rainer G
    Psychopharmacology (Berl); 2015 Jun; 232(12):2097-112. PubMed ID: 25529106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The endocannabinoid and endovanilloid systems interact in the rat prelimbic medial prefrontal cortex to control anxiety-like behavior.
    Fogaça MV; Aguiar DC; Moreira FA; Guimarães FS
    Neuropharmacology; 2012 Aug; 63(2):202-10. PubMed ID: 22691536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opposing effects of cannabinoids and vanilloids on evoked quantal release at the frog neuromuscular junction.
    Silveira PE; Silveira NA; Morini Vde C; Kushmerick C; Naves LA
    Neurosci Lett; 2010 Apr; 473(2):97-101. PubMed ID: 20176082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arvanil, anandamide and N-arachidonoyl-dopamine (NADA) inhibit emesis through cannabinoid CB1 and vanilloid TRPV1 receptors in the ferret.
    Sharkey KA; Cristino L; Oland LD; Van Sickle MD; Starowicz K; Pittman QJ; Guglielmotti V; Davison JS; Di Marzo V
    Eur J Neurosci; 2007 May; 25(9):2773-82. PubMed ID: 17459108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human brain endothelium: coexpression and function of vanilloid and endocannabinoid receptors.
    Golech SA; McCarron RM; Chen Y; Bembry J; Lenz F; Mechoulam R; Shohami E; Spatz M
    Brain Res Mol Brain Res; 2004 Dec; 132(1):87-92. PubMed ID: 15548432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabinoid CB1 receptor activation mediates the opposing effects of amphetamine on impulsive action and impulsive choice.
    Wiskerke J; Stoop N; Schetters D; Schoffelmeer AN; Pattij T
    PLoS One; 2011; 6(10):e25856. PubMed ID: 22016780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of TRPV1 channels in the activity of the cannabinoid WIN 55,212-2 in an acute rat model of temporal lobe epilepsy.
    Carletti F; Gambino G; Rizzo V; Ferraro G; Sardo P
    Epilepsy Res; 2016 May; 122():56-65. PubMed ID: 26970948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CB
    Medeiros P; Oliveira-Silva M; Negrini-Ferrari SE; Medeiros AC; Elias-Filho DH; Coimbra NC; de Freitas RL
    Brain Res Bull; 2020 Dec; 165():118-128. PubMed ID: 33038420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered responses of dopamine D3 receptor null mice to excitotoxic or anxiogenic stimuli: Possible involvement of the endocannabinoid and endovanilloid systems.
    Micale V; Cristino L; Tamburella A; Petrosino S; Leggio GM; Drago F; Di Marzo V
    Neurobiol Dis; 2009 Oct; 36(1):70-80. PubMed ID: 19591935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reciprocal changes in vanilloid (TRPV1) and endocannabinoid (CB1) receptors contribute to visceral hyperalgesia in the water avoidance stressed rat.
    Hong S; Fan J; Kemmerer ES; Evans S; Li Y; Wiley JW
    Gut; 2009 Feb; 58(2):202-10. PubMed ID: 18936104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anxiolytic-like effects induced by blockade of transient receptor potential vanilloid type 1 (TRPV1) channels in the medial prefrontal cortex of rats.
    Aguiar DC; Terzian AL; Guimarães FS; Moreira FA
    Psychopharmacology (Berl); 2009 Aug; 205(2):217-25. PubMed ID: 19387617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of cannabinoid and vanilloid drugs on positive and negative-like symptoms on an animal model of schizophrenia: the SHR strain.
    Almeida V; Peres FF; Levin R; Suiama MA; Calzavara MB; Zuardi AW; Hallak JE; Crippa JA; Abílio VC
    Schizophr Res; 2014 Mar; 153(1-3):150-9. PubMed ID: 24556469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of anxiety-like behaviour by Transient Receptor Potential Vanilloid Type 1 (TRPV1) channels located in the dorsolateral periaqueductal gray.
    Terzian AL; Aguiar DC; Guimarães FS; Moreira FA
    Eur Neuropsychopharmacol; 2009 Mar; 19(3):188-95. PubMed ID: 19064314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of cannabinoid CB1, CB2 and vanilloid TRPV1 receptor antagonists on cocaine addictive behavior in rats.
    Adamczyk P; Miszkiel J; McCreary AC; Filip M; Papp M; Przegaliński E
    Brain Res; 2012 Mar; 1444():45-54. PubMed ID: 22325096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential role of CB1 and TRPV1 receptors on anandamide modulation of defensive responses induced by nitric oxide in the dorsolateral periaqueductal gray.
    Lisboa SF; Guimarães FS
    Neuropharmacology; 2012 Jun; 62(8):2455-62. PubMed ID: 22394688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and/or vanilloid receptors in a rat model of multiple sclerosis.
    Cabranes A; Venderova K; de Lago E; Fezza F; Sánchez A; Mestre L; Valenti M; García-Merino A; Ramos JA; Di Marzo V; Fernández-Ruiz J
    Neurobiol Dis; 2005 Nov; 20(2):207-17. PubMed ID: 16242629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.